Wu Rui, Karagiannopoulos Alexandros, Eliasson Lena, Renström Erik, Luan Cheng, Zhang Enming
Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Lund University, 20502 Malmö, Sweden.
Biomedicines. 2022 Mar 25;10(4):770. doi: 10.3390/biomedicines10040770.
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are high-risk factors of diabetes development and may be caused by defective insulin secretion in pancreatic beta-cells. Glucose-stimulated insulin secretion is mediated by voltage-gated Ca (Ca) channels in which the gamma-4 subunit (Caγ4) is required for the beta-cell to maintain its differentiated state. We here aim to explore the involvement of Caγ4 in controlling glucose homeostasis by employing the mice to study in vivo glucose-metabolism-related phenotypes and glucose-stimulated insulin secretion, and to investigate the underlying mechanisms. We show that mice exhibit perturbed glucose homeostasis, including IFG and IGT. Glucose-stimulated insulin secretion is blunted in mouse islets. Remarkably, Caγ4 deletion results in reduced expression of the transcription factor essential for beta-cell maturation, MafA, on both mRNA and protein levels in islets from human donors and mice, as well as in INS-1 832/13 cells. Moreover, we prove that CaMKII is responsible for mediating this regulatory pathway linked between Caγ4 and MafA, which is further confirmed by human islet RNA-seq data. We demonstrate that Caγ4 is a key player in preserving normal blood glucose homeostasis, which sheds light on Caγ4 as a novel target for the treatment of prediabetes through correcting the impaired metabolic status.
空腹血糖受损(IFG)和糖耐量受损(IGT)是糖尿病发生的高危因素,可能由胰腺β细胞胰岛素分泌缺陷引起。葡萄糖刺激的胰岛素分泌由电压门控钙(Ca)通道介导,其中γ-4亚基(Caγ4)是β细胞维持其分化状态所必需的。我们在此旨在通过利用小鼠研究体内葡萄糖代谢相关表型和葡萄糖刺激的胰岛素分泌,探讨Caγ4在控制葡萄糖稳态中的作用,并研究其潜在机制。我们发现小鼠表现出葡萄糖稳态紊乱,包括IFG和IGT。葡萄糖刺激的胰岛素分泌在小鼠胰岛中减弱。值得注意的是,Caγ4缺失导致人供体和小鼠胰岛以及INS-1 832/13细胞中β细胞成熟所必需的转录因子MafA在mRNA和蛋白质水平上的表达降低。此外,我们证明CaMKII负责介导Caγ4和MafA之间的这种调节途径,这进一步得到人胰岛RNA测序数据的证实。我们证明Caγ4是维持正常血糖稳态的关键因素,这为通过纠正受损的代谢状态将Caγ4作为治疗糖尿病前期的新靶点提供了线索。